Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 17;23(22):14206.
doi: 10.3390/ijms232214206.

Anti-Proliferative Effects of Iridoids from Valeriana fauriei on Cancer Stem Cells

Affiliations

Anti-Proliferative Effects of Iridoids from Valeriana fauriei on Cancer Stem Cells

Hayato Yoshikawa et al. Int J Mol Sci. .

Abstract

We isolated seven new iridoid glucosides (valerianairidoids I-VII; 1-3, 6, 7, 9, and 12) and six known compounds from the methanol extract of the dried rhizomes and roots of Valeriana fauriei. Chemical and spectroscopic data were used to elucidate the chemical structures of the seven new iridoid glucosides, and their absolute configurations were determined by comparing their electronic circular dichroism (ECD) spectra with those determined experimentally. Aglycones 1a, 6a, and 9a, which were obtained by enzymatic hydrolysis of the isolated iridoid glucosides, exhibited anti-proliferative activities against cancer stem cells (CSCs) established by a sphere-formation assay using human breast cancer (MDA-MB-231) and human astrocytoma (U-251MG) cells. Interestingly, these iridoids selectively showed anti-proliferative activities against CSCs from MDA-MB-231 cells. These results suggest that the iridoids obtained in this study may have potency as a breast cancer treatment and as preventive agent via exterminating CSCs.

Keywords: ECD; Valeriana fauriei; cancer prevention; cancer stem cell; cancer treatment; valerianairidoid.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Chemical structures of constituents 113 isolated from V. fauriei and their derivatives 1a, 6a, and 9a.
Figure 2
Figure 2
Important 2D NMR correlations observed for new compounds 13, 6, 7, 9, and 12.
Figure 3
Figure 3
Important NOESY correlations observed for new compounds 13, 6, 7, 9, and 12.
Figure 4
Figure 4
Experimental and calculated ECD spectra for 1a, 6a, and 9a.

References

    1. Wang P.C., Ran X.H., Luo H.R., Hu J.M., Chen R., Ma Q.Y., Dai H.F., Liu Y.Q., Xie M.J., Zhou J., et al. Volvalerelactones A and B, Two New Sesquiterpenoid Lactones with an Unprecedented Skeleton from Valeriana officinalis var. latifolia. Org. Lett. 2011;13:3036–3039. doi: 10.1021/ol200878w. - DOI - PubMed
    1. Guo Y., Xu J., Li Y., Watanabe R., Oshima Y., Yamakuni T., Ohizumi Y. Iridoids and Sesquiterpenoids with NGF-Potentiating Activity from the Rhizomes and Roots of Valeriana fauriei. Chem. Pharm. Bull. 2006;54:123–125. doi: 10.1248/cpb.54.123. - DOI - PubMed
    1. Oshima Y., Matsuoka S., Ohizumi Y. Antidepressant Principles of Valeriana fauriei Roots. Chem. Pharm. Bull. 1995;43:169–170. doi: 10.1248/cpb.43.169. - DOI - PubMed
    1. Matsumoto T., Kitagawa T., Imahori D., Matsuzaki A., Saito Y., Ohta T., Yoshida T., Nakayama Y., Ashihara E., Watanabe T. Linderapyrone: A Wnt Signal Inhibitor Isolated from Lindera umbellate. Bioorg. Med. Chem. Lett. 2021;45:128161. doi: 10.1016/j.bmcl.2021.128161. - DOI - PubMed
    1. Matsumoto T., Imahori D., Achiwa K., Saito Y., Ohta T., Yoshida T., Kojima N., Yamashita M., Nakayama Y., Watanabe T. Chemical Structures and Cytotoxic Activities of the Constituents Isolated from Hibiscus tiliaceus. Fitoterapia. 2020;142:104524. doi: 10.1016/j.fitote.2020.104524. - DOI - PubMed